Theraclion S.A.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TCLIF research report →
Companywww.theraclion.com
Theraclion SA develops echotherapy solutions using high intensity focused ultrasound system. It offers SONOVEIN, a robotic solution for non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment and protects the patient's skin and optimizes the image quality. The company was founded in 2004 and is based in Malakoff, France.
- CEO
- Martin Deterre
- IPO
- 2019
- Employees
- 28
- HQ
- Malakoff, FR
Price Chart
Valuation
- Market Cap
- $25.09M
- P/E
- -4.99
- P/S
- 19.41
- P/B
- -10.97
- EV/EBITDA
- -5.27
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -528.16%
- Op Margin
- -424.37%
- Net Margin
- -479.76%
- ROE
- 222.05%
- ROIC
- -49.80%
Growth & Income
- Revenue
- $1.19M · 42.84%
- Net Income
- $-5,687,868 · 1.20%
- EPS
- $-0.09 · 22.00%
- Op Income
- $-6,378,609.8
- FCF YoY
- 0.00%
Performance & Tape
- 52W High
- $0.59
- 52W Low
- $0.00
- 50D MA
- $0.32
- 200D MA
- $0.08
- Beta
- 0.26
- Avg Volume
- 8
Get TickerSpark's AI analysis on TCLIF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our TCLIF Coverage
We haven't published any research on TCLIF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate TCLIF Report →